Neurogene Inc. (NGNE) Balance Sheet
NGNE balance sheet, 2025
December 31, 2025 · U.S. dollars$288.6M assets = $23.7M liabilities + $264.9M equity
Both columns are drawn to the same scale: what NGNE owns equals what it owes plus shareholders’ equity. Hover a block for its value.
NGNE financial health
Descriptive bands, not a rating. Fiscal 2025.
NGNE balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $154.4M2016 | $288.6M2025 | +7.2%/yr | |
| Total liabilities | $9.7M2016 | $23.7M2025 | +10.4%/yr | |
| Shareholders’ equity | $144.7M2016 | $264.9M2025 | +7.0%/yr | |
| Cash & short-term investments | $103.1M2016 | $269.0M2025 | +11.2%/yr | |
| Total debt | $47,0002016 | $9.9M2025 | +81.2%/yr | |
| Net cash (debt) | $103.0M2016 | $259.1M2025 | +$156.1M | |
| Working capital | $94.0M2016 | $255.4M2025 | +$161.4M | |
| Book value per share | $7.662016 | $12.512025 | +5.6%/yr | |
| Debt / equity | 0.002016 | 0.042025 | +0.04 | |
| Shares outstanding | 18.9M2016 | 21.2M2025 | +1.3%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
NGNE assets
NGNE liabilities and equity
NGNE debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
NGNE balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $269.0M | $312.4M | $197.2M | $82.0M | $70.5M | $192.6M | $143.1M | $76.9M | $108.1M | $103.1M |
| Cash & equivalents | $103.8M | $136.6M | $148.2M | $82.0M | $70.5M | $192.6M | $143.1M | $76.9M | $52.0M | $32.3M |
| Short-term investments | $165.2M | $175.8M | $48.9M | $58.5M | — | — | — | — | $56.1M | $70.8M |
| Receivables | $0 | $648,000 | $600,000 | $990,000 | $790,000 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $1.5M | $1.1M | $1.9M | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $2.8M | $2.9M | $1.1M | $630,000 | $711,000 | $2.0M | $503,000 | $237,000 | $740,000 | $426,000 |
| Total current assets | $271.8M | $315.9M | $200.3M | $84.7M | $74.0M | $194.5M | $143.6M | $77.2M | $108.8M | $103.5M |
| Property, plant & equipment (net) | $15.5M | $18.5M | $21.0M | $24.5M | $27.5M | $13.7M | $2.8M | $400,000 | $905,000 | $849,000 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $128,000 | $347,000 | $567,000 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $1.4M | $1.3M | $1.3M | $0 | $0 | $1.9M | $30,000 | $53,000 | $599,000 | $50.0M |
| Total assets | $288.6M | $335.7M | $222.6M | $109.3M | $101.5M | $210.5M | $147.0M | $77.6M | $110.3M | $154.4M |
| Liabilities | ||||||||||
| Accounts payable | $2.0M | $1.3M | $2.6M | $625,000 | $5.6M | $1.3M | $1.6M | $702,000 | — | — |
| Short-term debt | $3.1M | $3.0M | $2.9M | $702,000 | $1.8M | $708,000 | $618,000 | — | — | — |
| Deferred revenue | — | — | $16.8M | $5.2M | $4.3M | — | — | — | — | — |
| Total current liabilities | $16.4M | $15.2M | $23.0M | $6.7M | $10.9M | $7.9M | $4.7M | $4.6M | $11.0M | $9.5M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $11.0M | $14.2M | $16.3M | $4.7M | $5.2M | — | — | — | — | — |
| Other long-term liabilities | $7.3M | $10.2M | $13.6M | $4.0M | $182.5M | $11.4M | $593,000 | $319,000 | $486,000 | $197,000 |
| Total liabilities | $23.7M | $25.4M | $36.5M | $10.6M | $193.4M | $19.3M | $5.3M | $4.9M | $11.4M | $9.7M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | — | — | — | $1,000 | $1,000 | — | — | — | — | — |
| Retained earnings (deficit) | −$352.6M | −$262.3M | −$187.2M | −$150.8M | −$95.6M | −$332.8M | −$299.5M | −$230.1M | −$198.5M | −$148.3M |
| Accumulated other comprehensive income | — | — | — | $0 | $0 | — | — | — | −$70,000 | −$169,000 |
| Total shareholders' equity | $264.9M | $310.4M | $186.0M | $98.6M | −$91.9M | $191.2M | $141.7M | $72.7M | $98.9M | $144.7M |
| Key figures | ||||||||||
| Total debt | $9.9M | $12.4M | $16.3M | $4.7M | $6.4M | $12.1M | $1.2M | $6,000 | $32,999 | $47,000 |
| Net cash (debt) | $259.1M | $300.0M | $180.9M | $77.3M | $64.1M | $180.4M | $141.9M | $76.9M | $108.1M | $103.0M |
| Working capital | $255.4M | $300.8M | $177.4M | $78.1M | $63.1M | $186.6M | $138.9M | $72.5M | $97.9M | $94.0M |
| Tangible book value | $264.9M | $310.4M | $186.0M | $98.6M | −$92.0M | $190.9M | $141.1M | $72.7M | $98.9M | $144.7M |
| Book value per share | $12.51 | $17.67 | $14.51 | $7.69 | −$1.67 | $3.69 | $5.24 | $3.09 | $4.22 | $7.66 |
| Shares outstanding | 21.2M | 17.6M | 12.8M | 12.8M | 55.0M | 51.8M | 27.0M | 23.5M | 23.5M | 18.9M |
| Current ratio | 16.56 | 20.84 | 8.72 | 12.74 | 6.81 | 24.66 | 30.28 | 16.68 | 9.93 | 10.87 |
| Quick ratio | 16.39 | 20.65 | 8.61 | 12.48 | 6.57 | 24.41 | 30.17 | 16.63 | 9.87 | 10.83 |
| Debt / equity | 0.04 | 0.04 | 0.09 | 0.05 | — | 0.06 | 0.01 | 0.00 | 0.00 | 0.00 |
| Equity / assets | 91.8% | 92.4% | 83.6% | 90.3% | −90.5% | 90.8% | 96.4% | 93.6% | 89.6% | 93.7% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $225.4M | $243.2M | $269.0M | $265.4M | $274.5M | $292.6M | $312.4M | $139.0M | $153.9M | $169.5M | $197.2M | $78.5M |
| Cash & equivalents | $112.5M | $124.2M | $103.8M | $71.0M | $58.8M | $70.8M | $136.6M | $66.6M | $111.0M | $150.1M | $148.2M | $25.2M |
| Short-term investments | $112.9M | $119.0M | $165.2M | $194.4M | $215.7M | $221.8M | $175.8M | $72.4M | $42.9M | $19.4M | $48.9M | $53.3M |
| Receivables | $0 | $0 | $460,000 | $860,000 | $1.3M | $596,000 | $648,000 | $672,000 | $647,000 | $589,000 | $600,000 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $3.5M | $3.6M | $2.1M | $4.2M | $3.2M | $3.2M | $2.9M | $4.0M | $4.6M | $4.0M | $2.6M | $1.4M |
| Total current assets | $228.9M | $246.7M | $271.6M | $270.5M | $279.0M | $296.4M | $315.9M | $143.6M | $159.1M | $174.1M | $200.3M | $79.9M |
| Property, plant & equipment (net) | $14.0M | $15.0M | $15.5M | $15.9M | $16.9M | $17.7M | $18.5M | $19.3M | $19.5M | $20.1M | $21.0M | $9.2M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $1.4M | $1.4M | $2.1M | $1.4M | $1.4M | $1.2M | $1.3M | $1.1M | $1.1M | $1.1M | $1.3M | $524,000 |
| Total assets | $244.4M | $263.1M | $289.2M | $287.8M | $297.3M | $315.3M | $335.7M | $164.1M | $179.8M | $195.3M | $222.6M | $89.6M |
| Liabilities | ||||||||||||
| Accounts payable | $3.3M | $4.7M | $2.0M | $1.5M | $2.1M | $3.1M | $1.3M | $1.7M | $1.7M | $1.5M | $2.6M | $2.1M |
| Short-term debt | $3.0M | $3.0M | $3.1M | $3.7M | $4.3M | $4.2M | $3.0M | $3.7M | $2.8M | $2.7M | $2.9M | $2.3M |
| Deferred revenue | — | — | — | — | — | — | — | — | — | — | — | −$2,134 |
| Total current liabilities | $21.5M | $18.9M | $16.4M | $14.7M | $15.4M | $14.1M | $15.2M | $15.8M | $13.1M | $11.8M | $23.0M | $5.2M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $8.8M | $9.5M | $11.0M | $11.3M | $12.9M | $13.5M | $14.2M | $14.5M | $15.9M | $15.7M | $16.3M | — |
| Other long-term liabilities | $5.7M | $6.5M | $7.9M | $7.6M | $8.6M | $9.4M | $10.2M | $10.9M | $11.7M | $12.8M | $13.6M | $9.1M |
| Total liabilities | $27.2M | $25.4M | $24.3M | $22.3M | $24.1M | $23.5M | $25.4M | $26.7M | $24.8M | $24.6M | $36.5M | $14.4M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | — | — | — | — | — | — | — | — | — | $170.8M | — | $1,000 |
| Retained earnings (deficit) | −$418.1M | −$383.6M | −$352.6M | −$327.9M | −$307.0M | −$284.9M | −$262.3M | −$242.8M | −$222.6M | −$204.1M | −$187.2M | −$471.9M |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | — | — | — | — | −$244,367 |
| Total shareholders' equity | $217.1M | $237.8M | $264.9M | $265.5M | $273.3M | $291.8M | $310.4M | $137.4M | $155.0M | $170.8M | $186.0M | $75.2M |
| Key figures | ||||||||||||
| Total debt | $8.3M | $9.1M | $9.9M | $11.3M | $12.9M | $13.5M | $12.4M | $14.5M | $13.8M | $14.4M | $16.3M | $11.5M |
| Net cash (debt) | $217.0M | $234.1M | $259.1M | $254.1M | $261.7M | $279.1M | $300.0M | $124.5M | $140.1M | $155.1M | $180.9M | $67.0M |
| Working capital | $207.4M | $227.9M | $255.2M | $255.8M | $263.5M | $282.3M | $300.8M | $127.8M | $146.1M | $162.3M | $177.4M | $74.7M |
| Tangible book value | $217.1M | $237.8M | $264.9M | $265.5M | $273.3M | $291.8M | $310.4M | $137.4M | $155.0M | $170.8M | $186.0M | $75.2M |
| Book value per share | $9.63 | $10.66 | $17.10 | $12.54 | $12.98 | $13.90 | $20.89 | $8.11 | $9.15 | $10.10 | $14.51 | $6.78 |
| Shares outstanding | 22.6M | 22.3M | 15.5M | 21.2M | 21.1M | 21.0M | 14.9M | 17.0M | 16.9M | 16.9M | 12.8M | 11.1M |
| Current ratio | 10.64 | 13.08 | 16.55 | 18.39 | 18.07 | 21.03 | 20.84 | 9.09 | 12.17 | 14.74 | 8.72 | 15.33 |
| Quick ratio | 10.48 | 12.89 | 16.42 | 18.10 | 17.86 | 20.80 | 20.65 | 8.84 | 11.82 | 14.40 | 8.61 | 15.06 |
| Debt / equity | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.04 | 0.11 | 0.09 | 0.08 | 0.09 | 0.15 |
| Equity / assets | 88.9% | 90.4% | 91.6% | 92.3% | 91.9% | 92.5% | 92.4% | 83.7% | 86.2% | 87.4% | 83.6% | 84.0% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 24, 2026); data from EODHD.
NGNE financial position
At the end of fiscal 2025 (December 31, 2025), Neurogene had total assets of $288.6 million (down 14.0% from a year earlier), total liabilities of $23.7 million and shareholders' equity of $264.9 million. It held $269.0 million in cash and short-term investments against $9.9 million of debt, a net cash position of $259.1 million. Its current ratio was 16.56. In the latest quarter (ended June 30, 2026) total assets were $244.4 million and equity $217.1 million.
Related: NGNE income statement, NGNE cash flow statement, NGNE key metrics. See the NGNE stock overview for the latest quote and news.
NGNE balance sheet FAQ
What are Neurogene's total assets?
Neurogene reported total assets of $288.6 million at the end of fiscal 2025 (December 31, 2025), compared with $335.7 million a year earlier.
How much debt does Neurogene have?
Neurogene had $9.9 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.04.
How much cash does Neurogene have?
Neurogene held $269.0 million in cash and short-term investments at the end of fiscal 2025; with $9.9 million of debt that is net cash of $259.1 million.
What is Neurogene's book value?
Neurogene's shareholders' equity (book value) was $264.9 million at the end of fiscal 2025, or $12.51 per share.
What is Neurogene's current ratio?
Neurogene had current assets of $271.8 million and current liabilities of $16.4 million, a current ratio of 16.56 (it can cover its short-term obligations).